Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival
Abstract
Long-term estrogen inhibition may cause fatty liver disease (non-alcoholic fatty liver disease; NAFLD) among other adverse conditions such as osteoporosis, climacteric symptoms, thromboembolism, dyslipidemia, and metabolic syndrome. The prevalence of NAFLD among breast cancer patients ranges from 2.3%-45.2%. This study aimed to determine the risk factors for newly developed NAFLD among breast cancer patients after hormonal treatment and whether...
Paper Details
Title
Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival
Published Date
Jan 1, 2021
Journal
Volume
24
Issue
5
Pages
417 - 417
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History